Document is current
Any future updates will be listed below
-
Authors
Chhabra, Yash https://orcid.org/0000-0003-2883-4675
Jagirdar, Kasturee R.
Galluzzi, Lorenzo https://orcid.org/0000-0003-2257-8500
- License Information
-
More Information
Article History
Received: 13 January 2026
Accepted: 23 January 2026
First Online: 4 February 2026
Competing interests
: LG is holding research contracts with Lytix Biopharma, Promontory and Onxeo; has received consulting/advisory honoraria from Boehringer Ingelheim, AstraZeneca, AbbVie, OmniSEQ, Onxeo, The Longevity Labs, Inzen, Imvax, Sotio, Promontory, Noxopharm, EduCom, and the Luke Heller TECPR2 Foundation; and holds Promontory stock options. YC and KRJ have no conflicts to declare.
